ISM-5059

N/A

Report date: 2026/02/06 20:01:23
NME

Base Information

Drug NameISM-5059
Drug Alias NameISM5059ISM-5059
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsInflammationMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInSilico Medicine Hong Kong Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInSilico Medicine Hong Kong Ltd
Inactive CompaniesN/A
Active IndicationsInflammationMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A